Joshua Ruch is Director at GeneDx Holdings Corp. (WGS). They have made 2 open-market trades across 2 companies since 2015, most recently 2026-06-18.
CIK 0000943431
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5.7M since 2015, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ITEK | 2,870,584 | $34.9M |
| GNVC | 3,378,410 | $24.3M |
| WGS | 33,299 | $2.1M |
| SMFR | 17,114 | $5K |
| VRNM | 482,190 | — |
| Total | $61.3M |
Shares reported on the most recent Form 4, priced at the 2026-06-23 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.